Joins Irish trade body for pharma as plan to cut country’s drug prices agreed
The Irish Pharmaceutical Healthcare Association (IPHA) has appointed Janssen's Dr Leisha Daly as vice president.
Dr Daly, who serves as country director at Janssen, joins the trade body at a crucial time for the pharma industry in Ireland, with the IPHA this week agreeing plans with the Department of Health and Health Service Executive (HSE) to cut the price of hundreds of medicines by an average of 10 per cent.
She takes over from Pfizer's David Gallagher as vice president, following his two years in the position, and will serve alongside fellow vice president Dr Neil Boyle of MSD.
In addition to her role at Janssen, Dr Daly has served on the IPHA board of directors since June, 2012, and was appointed to the prescription medicines division strategy board in August, 2012.
Dr Daly joined Janssen in 1998 as head of technical affairs, rising up the ranks to hold a variety of senior positions in medical, sales and marketing, before being appointed to her current position in March, 2012.
Prior to joining Janssen, Dr Daly served at Hoechst Ireland having spent several years in academic clinical research.